Headquartered in suburban Pittsburgh, Pennsylvania, Mylan Pharmaceuticals is an international conglomerate with more than a dozen divisions and subsidiaries in more than 20 countries, most prominently in India. Although its reputation in drug development was firmly established by the late 1980s, Mylan at the time embarked on the development and introduction of generic versions of many name-brand drugs. Mylan’s research and development branches worked in particular on drugs designed to treat sexually transmitted diseases and pulmonary stress disorders. In both cases, Mylan stressed in its promotional materials its goal of satisfying what the company termed “unmet needs,” emphasizing the company’s focus on producing generic versions of medications that are generally sold at a lower cost than their brand-name equivalents. Mylan, which employs more than ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles